Where does the product fit?
Define the clinical setting, current pathway, decision point, users and the operational change the product would introduce.
NHS market access for medtech
Build adoption into the strategy from the start.
Genvissa helps medtech teams connect product value, clinical workflow, evidence, economics, procurement and implementation around a credible route into NHS use.
The adoption question
Who changes which decision, and why?
Market access becomes practical when the real healthcare decision is defined.
A general claim that a technology saves time, money or improves outcomes is not enough. The proposition must show where the product fits, who uses it, whose budget is affected, what evidence they require and what operational change is needed.
Genvissa works backwards from that decision to shape the value proposition, evidence plan, health-economic logic, pilot design, stakeholder strategy and commercial route.
Market-access framework
Six questions that determine adoption.
Who benefits?
Separate benefits for patients, clinicians, providers, systems and commissioners so value is relevant to each stakeholder.
What must be proven?
Identify the clinical, operational, usability and economic questions that will determine confidence, procurement and scale.
Where does the impact land?
Map costs, capacity, resource use, avoided activity and budget consequences across the organisations involved.
Who decides and pays?
Clarify commissioning, procurement, local governance, funding routes, evaluation requirements and practical entry points.
What makes use sustainable?
Plan implementation, training, workflow integration, service ownership, data collection and the transition from pilot to routine use.
Stakeholder and decision map
A clear view of users, influencers, budget holders, procurement roles, blockers and the sequence of decisions required.
Value proposition
A healthcare-native account of the problem, pathway, product role, evidence, economic logic and value for each decision-maker.
Evidence-gap plan
A prioritised plan for the clinical, operational, usability and economic evidence needed for the next access decision.
Pilot and entry strategy
A practical route through sites, partners, study design, procurement, pricing, implementation and scale-up planning.
Common pitfalls
The market-access work that cannot wait until launch.
Generating data that does not answer the buyer's question
Studies should be designed around the decisions required for adoption, not only the easiest endpoint to measure.
Claiming savings without showing where they occur
Economic value must be linked to a real pathway, time horizon, resource and accountable budget holder.
Running activity without a scale decision
A useful pilot has an owner, agreed learning objectives, predefined success criteria and a credible next procurement or implementation step.
From approval to use
Build the evidence and route around a real NHS decision.
Start with the pathway, stakeholder or market-access question that currently lacks a credible answer.